A | |||||||
In silico evaluation of qRT-PCR Kits with SARS-CoV-2 Delta Variant | |||||||
 | Alignment results with global Delta sequences (First level screening analysis) | Alignment results with Indian Delta sequences (Second level screening analysis) | Overall resultsa | ||||
Type of Kit | Total number of kits | No. satisfactory | % satisfactory | No. of kits | No. satisfactory | % satisfactory | Overall satisfactory % |
One gene | 3 | 2 | 67 | 0 | NA | NA | 67 |
Two gene | 53 | 39 | 74 | 1 | 1 | 100 | 75 |
Three gene | 16 | 13 | 81 | 2 | 0 | 0 | 81 |
Four gene | 1 | 1 | 100 | 0 | NA | NA | 100 |
Total | 73 | 55 | 75 | 3 | 1 | 33 | 77 |
B | |||||||
In silico evaluation of qRT-PCR Kits with SARS-CoV-2 Omicron Variant | |||||||
 | Alignment results with global Omicron sequences (First level screening analysis) | Alignment results with Indian Omicron sequences (Second level screening analysis) | Overall resultsa | ||||
Type of Kit | Total number of kits | No. satisfactory | % satisfactory | No. of kits | No. satisfactory | % satisfactory | Overall satisfactory % |
One gene | 3 | 1 | 33 | 2 | 1 | 50 | 67 |
Two gene | 53 | 34 | 64 | 16 | 12 | 75 | 87 |
Three gene | 16 | 13 | 81 | 2 | 2 | 100 | 94 |
Four gene | 1 | 1 | 100 | 0 | NA | NA | 100 |
Total | 73 | 49 | 67 | 20 | 15 | 75 | 88 |